| Front page | | Contents | | Previous | | Next |
Appendices 1-18 to: Report on the Health Effects of Selected Pesticide Coformulants
135 References
At (2002). Grænseværdier for stoffer og materialer. Arbejdstilsynets At-vejledning C.0.1, oktober 2002.
Beaulieu HJ and Schmerber KR (1991). M-PyrolÔ (NMP) use in the microelectronics industry. Appl Occup Environ Hyg 6, 874-880.
Fries AS, Hass U, Jakobsen BM, Jelnes JE, Lund SP and Simonsen L (1992). N-methylpyrrolidons effekter på fosterudvikling, centralnervesystem, testikler og sæd hos rotter. Arbejdsmiljøfondet, København.
Hass U, Jakobsen BM and Lund SP (1995). Developmental toxicity of inhaled N-methylpyrrolidone in the rat. Pharmacol Toxicol 76, 406-509.
Hass U, Lund SP and Elsner J (1994). Effects of prenatal exposure to N-methylpyrrolidone on postnatal development and behaviour in rats. Neurotoxicol Teratol 16, 241-249.
HSDB (2001). 1-Methyl-2-pyrrolidinone. In: Hazardous Substances Data Base.
IUCLID (2000). 1-Methyl-2-pyrrolidone. In: International Uniform Chemical Information Database. Existing Chemicals 2000. ECB, JCR, Ispra.
Lee KP, Chromey NC, Culik R, Barnes JR and Schneider PW (1987). Toxicity of N-methyl -2-pyrrolidone (NMP): Teratogenic, subchronic and two-year inhalation studies. Fundam Appl Toxicol 9, 222-235.
Malley LA, Kennedy GL, Elliott GS, Slone TW, Mellert W, Deckardt K, Gembardt C, Hildebrand B, Parod RJ, McCarthy TJ and Griffiths JC (1999). 90-Day subchronic toxicity study in rats and mice fed N-methylpyrrolidone (NMP) including neurotoxicity evaluation in rats. Drug Chem Toxicol 22, 455-480.
Merck Index (1996). 1-Methylyrrolidone. 12th. ed., Rahway, New Jersey, Merck & Co., Inc., 1043.
Midgley I, Hood AJ, Chasseaud LF, Brindley CJ, Baughman S and Allan G (1992). Percutaneous absorption of co-administered N-methyl-2-[14C]pyrrolidinone and 2-[14C] pyrrolidinone in the rat. Fd Chem Toxicol 30, 57-64.
MM (2002). The Statutory Order from the Ministry of the Environment no. 439 of June 3, 2002, on the List of Chemical Substances.
MST (1990). Begrænsning af luftforurening fra virksomheder. Vejledning fra Miljøstyrelsen nr. 6 1990.
Saillenfait AM, Gallissot F and Morel G (2003). Developmental toxicity of N-methyl-2-pyrrolidone in rats following inhalation exposure. Fd Chem Toxicol 41, 583-588.
Solomon GM, Morse EP, Garbo MJ and Milton DK (1996). Stillbirth after occupational exposure to N-methyl-2-pyrrolidone. J Occup Environ Med 38, 705-713.
TOXLINE PLUS 1999-2000/01.
Trochimowicz HL et al. (1994). N-methyl-2-pyrrolidinone. In: Clayton GD, Clayton FE eds. Patty‘s Industrial Hygiene and Toxicology, 4th. ed. John Wiley & Sons, Inc, Vol IIE, 3309-3312.
Wells DA and Digenis GA (1988). Disposition and metabolism of double-labeled [3H and 14C] N-methyl-2-pyrrolidinone in the rat. Drug Metab Disp 16, 243-249.
Åkesson B (1994). N-Methyl-2-pyrrolidone (NMP). Arbete och Hälsa 1994:40. Nordic Expert Group for Criteria Documentation of Health Risks from chemicals. Arbetarskyddsverket.
Åkesson B and Paulsson K (1997). Experimental exposure of male volunteers to N-methyl-2-pyrrolidone (NMP): acute effects and pharmacokinetics of NMP in plasma and urine. Occup Environ Med 54, 236-240.
| Front page | | Contents | | Previous | | Next | | Top |
|